Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Hoenigl, M; Salmanton-García, J; Walsh, TJ; Nucci, M; Neoh, CF; Jenks, JD; Lackner, M; Sprute, R; Al-Hatmi, AMS; Bassetti, M; Carlesse, F; Freiberger, T; Koehler, P; Lehrnbecher, T; Kumar, A; Prattes, J; Richardson, M; Revankar, S; Slavin, MA; Stemler, J; Spiess, B; Taj-Aldeen, SJ; Warris, A; Woo, PCY; Young, JH; Albus, K; Arenz, D; Arsic-Arsenijevic, V; Bouchara, JP; Chinniah, TR; Chowdhary, A; de, Hoog, GS; Dimopoulos, G; Duarte, RF; Hamal, P; Meis, JF; Mfinanga, S; Queiroz-Telles, F; Patterson, TF; Rahav, G; Rogers, TR; Rotstein, C; Wahyuningsih, R; Seidel, D; Cornely, OA.
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.
Lancet Infect Dis. 2021; 21(8):e246-e257 Doi: 10.1016/S1473-3099(20)30784-2
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Hönigl Martin
Co-Autor*innen der Med Uni Graz
Prattes Jürgen
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World-One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.
Find related publications in this database (using NLM MeSH Indexing)
Animals - administration & dosage
Disease Management - administration & dosage
Fungi - drug effects, genetics, isolation & purification, physiology
Humans - administration & dosage
Mycology - administration & dosage
Mycoses - diagnosis, drug therapy, microbiology
Practice Guidelines as Topic - administration & dosage
Societies, Medical - administration & dosage

© Med Uni Graz • Impressum